EDGAR Filing Documents for 0000950134-96-002829

Form SB-2 - Optional form for registration of securities to be sold to the public by small business issuers:

SEC Accession No. 0000950134-96-002829

Filing Date

1996-06-12

Accepted

1996-06-12 00:00:00

Documents

SROs

NASD

Document Format Files

Seq	Description	Document	Type	Size
1	FORM SB-2		SB-2	336467
2	OPINION OF BINGHAM, DANA & GOULD, L.L.P.		EX-5.1	3439
3	CONSENT OF KPMG PEAT MARWICK LLP		EX-23.(B)	723
4	CONSENT OF KPMG PEAT MARWICK LLP		EX-23.(C)	896
5	CONSENT OF SMITH ANGLIN & CO.		EX-23.(D)	725
	Complete submission text file	0000950134-96-002829.txt		344314

Mailing Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207

Business Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207 2149055100

ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)